Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects

Javad Masoumi; Abdollah Jafarzadeh; Jalal Abdolalizadeh; Haroon Khan; Jeandet Philippe; Hamed Mirzaei; Hamid Reza Mirzaei

doi:10.1016/j.apsb.2020.12.015

Journal Articles Acta Pharmaceutica Sinica B Year : 2020

Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects

, , , , (1) , ,

1

Javad Masoumi

Function : Author

Abdollah Jafarzadeh

Function : Author

Jalal Abdolalizadeh

Function : Author

Haroon Khan

Function : Author

Jeandet Philippe

Function : Author

Résistance Induite et Bioprotection des Plantes - EA 4707

Hamed Mirzaei

Function : Author

Hamid Reza Mirzaei

Function : Author

Domains

Life Sciences [q-bio]

ISABELLE ROBERRINI : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03115353

Submitted on : Tuesday, January 19, 2021-3:38:59 PM

Last modification on : Thursday, May 18, 2023-3:55:35 AM

Dates and versions

hal-03115353 , version 1 (19-01-2021)

Identifiers

HAL Id : hal-03115353 , version 1
DOI : 10.1016/j.apsb.2020.12.015
PUBMEDCENTRAL : PMC8343118

Cite

Javad Masoumi, Abdollah Jafarzadeh, Jalal Abdolalizadeh, Haroon Khan, Jeandet Philippe, et al.. Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects. Acta Pharmaceutica Sinica B, 2020, ⟨10.1016/j.apsb.2020.12.015⟩. ⟨hal-03115353⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS URCA RIBP

7 View

0 Download

Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share